ASCO Meeting Highlights
With finite healthcare resources, do physicians have a duty to serve society broadly by being responsible stewards of those shared resources, or is their obligation to the patients before them incompatible with any rationing? The balance of duties to patients and to society was the subject of a debate at the 2014 American Society of Clinical Oncology (ASCO) meeting.
Delaying ADT for PSA-Only Relapse May Be a Viable Option for Men with Prostate Cancer and PSA-Only Relapses
Delaying androgen deprivation therapy (ADT) for at least 2 years did not lead to worse overall survival or prostate cancer–specific survival compared with the initiation of ADT within 3 months of rising prostate-specific antigen (PSA) in men with PSA-only relapse (ie, biochemical relapse) after the primary treatment of prostate cancer with surgery or radiation, according to the results of a large population-based study presented at the 2014 American Society of Clinical Oncology (ASCO) meeting and highlighted at a press briefing.
A majority of oncologists, patients with cancer, and members of the general public support cutting healthcare costs by refusing to pay for drugs that do not improve survival rates or quality of life. This is according to the results of a new study that were presented by researchers from the Perelman School of Medicine at the University of Pennsylvania during the annual meeting of the American Society of Clinical Oncology in Chicago.
University Hospitals Case Medical Center Experts Present Data Addressing Patient and Physician Barriers to Clinical Trials
Researchers from University Hospitals Case Medical Center (UHCMC)’s Seidman Cancer Center presented findings from 2 studies evaluating new technologies designed to address common barriers to patient enrollment in clinical trials at the annual meeting of the American Society of Clinical Oncology (ASCO) in Chicago.
The American Society of Clinical Oncology (ASCO) has completed the first phase in developing several sets of interoperability standards for cancer care data and overcoming the widespread inconsistencies that currently limit secure sharing of information between providers, patients, and researchers.
Results 1 - 5 of 5